Drug metabolism in mixed human liver microsomes assessed as metabolite 7-2 ((2S,3S,4S,5R,6S)-6-(2-((2R,5S)-5-((3S,5R,8R,9R,10R,12R,14R,17S)-3,12-dihyd...

ID: ALA3527660

Type: ADME

Description: Drug metabolism in mixed human liver microsomes assessed as metabolite 7-2 ((2S,3S,4S,5R,6S)-6-(2-((2R,5S)-5-((3S,5R,8R,9R,10R,12R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-5-methyltetrahydrofuran-2-yl)propan-2-yloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid) formation at 50 uM after 120 mins by liquid chromatography-electrospray ionization ion trap mass spectrometry in presence of UDPGA

Format: BAO_0000019

Organism: Homo sapiens

Tissue: Liver

Target:  Liver microsome(ALA2367379)

Document:  ALA3525992

Drug metabolism in mixed human liver microsomes assessed as metabolite 7-2 ((2S,3S,4S,5R,6S)-6-(2-((2R,5S)-5-((3S,5R,8R,9R,10R,12R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-5-methyltetrahydrofuran-2-yl)propan-2-yloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid) formation at 50 uM after 120 mins by liquid chromatography-electrospray ionization ion trap mass spectrometry in presence of UDPGA: 1